Oncocyte Corp (OCX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	8-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	1.0	7.7	1.2	0.0	0.0	0.0	0.0	0.0
Revenue growth	-87.6%	535.4%
Cost of goods sold	1.0	4.2	1.9	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	3.5	-0.6	0.0	0.0	0.0	0.0	0.0
Gross margin	-1.9%	45.8%	-52.5%
Selling, general and administrative [+]	23.0	33.5	23.3	15.4	8.7	11.7	5.5	4.2
Sales and marketing	1.1	11.2	6.5	2.2	1.7	2.4	1.2	0.3
General and administrative	21.9	22.3	16.8	13.3	7.0	9.2	4.3	3.9
Research and development	7.3	13.6	9.8	6.8	6.5	7.2	5.7	4.5
Equity in earnings		0.3	1.5	-0.3
Other operating expenses		30.6	-4.0
EBITDA [+]		-69.7	-27.8	-22.2	-14.6	-18.3	-10.8	-8.4
EBITDA growth	-56.5%	151.1%	25.2%	51.4%	-19.8%	69.9%	27.5%	79.8%
EBITDA margin	-3166.2%	-902.5%	-2283.7%
Depreciation		0.8	0.3	0.3	0.4	0.3	0.1	0.0
EBITA	-30.3	-70.6	-28.1	-22.5	-15.1	-18.6	-10.9	-8.5
EBITA margin	-3166.2%	-913.4%	-2309.5%
Amortization of intangibles		3.4	0.1		0.1	0.2	0.2	0.2
EBIT [+]	-30.3	-73.9	-28.2	-22.5	-15.2	-18.8	-11.1	-8.7
EBIT growth	-59.0%	162.5%	25.1%	48.1%	-19.3%	69.2%	27.8%	75.3%
EBIT margin	-3166.2%	-956.9%	-2316.1%
Non-recurring items [+]	-12.3
Asset impairment	18.7
Unusual expense	-31.0
Interest expense, net [+]		0.2	0.3	-0.3	0.2	0.2	0.0	0.0
Interest expense		0.2	0.3		0.2	0.2	0.0	0.0
Interest income				0.3
Other income (expense), net [+]	-0.6	0.8	-2.8	-0.2	-0.3	-0.3		0.0
Gain (loss) on debt retirement		1.1		-0.2
Change in value of contingent liability		27.3	-4.0
Other	-0.6	0.0	0.0	0.0	0.1	-0.3		0.0
Pre-tax income	-18.6	-73.4	-31.2	-22.4	-15.8	-19.4	-11.2	-8.7
Income taxes	0.0	-9.3	-1.3	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	12.6%	4.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-72.9	-64.1	-29.9	-22.4	-15.8	-19.4	-11.2	-8.7
Net margin	-7609.8%	-829.5%	-2461.5%

Basic EPS [+]		($0.72)	($0.46)	($0.44)	($0.42)	($0.64)	($0.42)	($0.42)
Growth		57.7%	4.6%	5.0%	-35.1%	52.4%	1.3%	51.8%
Diluted EPS [+]		($0.72)	($0.46)	($0.44)	($0.42)	($0.64)	($0.42)	($0.42)
Growth		57.7%	4.6%	5.0%	-35.1%	52.4%	1.3%	51.8%

Shares outstanding (basic) [+]		88.9	65.5	51.3	37.9	30.2	26.5	21.0
Growth		35.8%	27.6%	35.5%	25.4%	13.8%	26.3%	15.4%
Shares outstanding (diluted) [+]		88.9	65.5	51.3	37.9	30.2	26.5	21.0
Growth		35.8%	27.6%	35.5%	25.4%	13.8%	26.3%	15.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.